BackMarinus Pharmaceuticals Overview

Marinus Pharmaceuticals Total Assets

Marinus Pharmaceuticals's total assets is $64M.

Get informed when a big investor buys or sells

+ Follow
Total Assets
$63.62M
68.32% YoYΔ $-137.18M vs prior year quarter

Peer trimmed avg / median

Loading

Marinus Pharmaceuticals Total Assets History

Loading

Marinus Pharmaceuticals vs. peers: Total Assets Comparison

Loading

Marinus Pharmaceuticals Total Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Marinus Pharmaceuticals (MRNS) FAQ

As of the most recent data (September 2024), MRNS shows a total assets of $64M. That compares with $200M in the prior-year period — down 68.3% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, MRNS's total assets is now $64M (was $200M) — a 68.3% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Marinus Pharmaceuticals is outperforming or lagging.

Tracking MRNS's total assets over time shows whether Marinus Pharmaceuticals is scaling, shrinking, or reshaping that part of the business. The current reading is $64M That compares with $200M in the prior-year period — down 68.3% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total assets page, Stockcircle has Marinus Pharmaceuticals's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total assets (currently $64M) with ownership activity and broader fundamentals.

Marinus Pharmaceuticals's total assets is $64M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.